Dupilumab treatment increases transitional B-cells (regulatory B-cells) in severe asthma
M. Lommatzsch (Rostock, Germany), M. Dost (Rostock, Germany), N. Jaishankar (Rostock, Germany), M. Weise (Rostock, Germany), P. Stoll (Rostock, Germany), J. Virchow (Rostock, Germany), K. Bratke (Rostock, Germany)
Source: International Congress 2022 – New insights into asthma immunology: from mouse to man
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lommatzsch (Rostock, Germany), M. Dost (Rostock, Germany), N. Jaishankar (Rostock, Germany), M. Weise (Rostock, Germany), P. Stoll (Rostock, Germany), J. Virchow (Rostock, Germany), K. Bratke (Rostock, Germany). Dupilumab treatment increases transitional B-cells (regulatory B-cells) in severe asthma. 925
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|